From Clinical Trials to the Real-World Practice


Basile, P.; Falagario, A.; Carella, M.C.; Dicorato, M.M.; Monitillo, F.; Santoro, D.; Naccarati, M.L.; Pontone, G.; Ciccone, M.M.; Santobuono, V.E.;
et al. Eligibility of Outpatients with Chronic Heart Failure for Vericiguat and Omecamtiv Mecarbil: From Clinical Trials to the Real-World Practice. J. Clin. Med. 2025, 14, 1951.
https://doi.org/10.3390/jcm14061951

AMA Style

Basile P, Falagario A, Carella MC, Dicorato MM, Monitillo F, Santoro D, Naccarati ML, Pontone G, Ciccone MM, Santobuono VE,
et al. Eligibility of Outpatients with Chronic Heart Failure for Vericiguat and Omecamtiv Mecarbil: From Clinical Trials to the Real-World Practice. Journal of Clinical Medicine. 2025; 14(6):1951.
https://doi.org/10.3390/jcm14061951

Chicago/Turabian Style

Basile, Paolo, Alessio Falagario, Maria Cristina Carella, Marco Maria Dicorato, Francesco Monitillo, Daniela Santoro, Maria Ludovica Naccarati, Gianluca Pontone, Marco Matteo Ciccone, Vincenzo Ezio Santobuono,
and et al. 2025. “Eligibility of Outpatients with Chronic Heart Failure for Vericiguat and Omecamtiv Mecarbil: From Clinical Trials to the Real-World Practice” Journal of Clinical Medicine 14, no. 6: 1951.
https://doi.org/10.3390/jcm14061951

APA Style

Basile, P., Falagario, A., Carella, M. C., Dicorato, M. M., Monitillo, F., Santoro, D., Naccarati, M. L., Pontone, G., Ciccone, M. M., Santobuono, V. E., & Guaricci, A. I.

(2025). Eligibility of Outpatients with Chronic Heart Failure for Vericiguat and Omecamtiv Mecarbil: From Clinical Trials to the Real-World Practice. Journal of Clinical Medicine, 14(6), 1951.
https://doi.org/10.3390/jcm14061951



Source link

Paolo Basile www.mdpi.com